United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 29, 2026 · Filed Sep 30, 2026

On Sep 29, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$477.42 for US$4.54M under a trading plan, leaving 324,443 shares. Filed Sep 30, 2026 (Form 4).

Sold
9,500 shares
Price
US$477.42 average (US$472.05 to US$486.77)
Value
US$4.54M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 29, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 29, 2026Common StockSale400US$472.05333,543Indirect
Sep 29, 2026Common StockSale449US$472.97333,094Indirect
Sep 29, 2026Common StockSale80US$473.86333,014Indirect
Sep 29, 2026Common StockSale552US$475.12332,462Indirect
Sep 29, 2026Common StockSale1,395US$476.10331,067Indirect
Sep 29, 2026Common StockSale2,135US$477.09328,932Indirect
Sep 29, 2026Common StockSale2,309US$478.10326,623Indirect
Sep 29, 2026Common StockSale1,200US$479.07325,423Indirect
Sep 29, 2026Common StockSale160US$479.59325,263Indirect
Sep 29, 2026Common StockSale500US$481.22324,763Indirect
Sep 29, 2026Common StockSale120US$482.28324,643Indirect
Sep 29, 2026Common StockSale200US$486.77324,443Indirect

Source

View original at SEC

Related